Page 93 - medicina-integrativa_compress

84 PARTE II, SECCIÓN 1 TRASTORNOS AFECTIVOS

BIBLIOGRAFÍA 28. Bottiglieri T, Laundy M, Crellin R, et al: Homocysteine, folate,
methylation, and monoamine metabolism in depression. J Neurol
1. Eisenberg DM, Davis RB, Ettner SL, et al: Trends in alternative Neurosurg Psychiatry 69:228-232, 2000.
medicine use in the United States, 1990-1997: Results of a follow-up 29. Alpert JE, Fava M: Nutrition and depression: The role of folate.
national survey. JAMA 280:1569-1575, 1998. Nutr Rev 55:145-149, 1997.
2. Angst J, Sellaro R, Marikargas KR: Depressive spectrum diagnoses. 30. Taylor MJ, Carney S, Geddes J, et al: Folate for depressive disorders.
Compr Psychiatry 41(Suppl 1):39-47, 2000. Cochrane Database Syst Rev (2):CD003390, 2003.
3. Lowe B, Unutzer J, Callahan CM, et al: Monitoring depression 31. Delle CR, Pancheri P, Scapicchio P: Efficacy and tolerability of oral
treatment outcomes with the Patient Health Questionnaire-9. Med and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate
Care 42:1194-1201, 2004. (SAMe) in the treatment of major depression: Comparison with
4. Post RM: Transduction of psychosocial stress into the neurobiology imipramine in two multicenter studies. Am J Clin Nutr
of recurrent affective disorder. Am J Psychiatry 149:999-1010, 1992. 76(Suppl):1172S-1176S, 2002.
5. Duman R, Heninger G, Nestler E: A molecular and cellular theory of 32. Bressa GM: SAMe as antidepressant: Meta-analysis of clinical
depression. Arch Gen Psychiatry 54:597-606, 1997. studies. Acta Neurol Scand Suppl 154:7-14, 1994.
6. Kirby S: The positive effect of exercise as a therapy for clinical 33. Meyers S: Use of neurotransmitter precursors for treatment of
depression. Nurs Times 101:28-29, 2004. depression. Altern Med Rev 5:64-71, 2000.
7. Freemont J, Craighead LW: Aerobic exercise and cognitive therapy 34. Murray M, Pizzorno J: Affective disorders. In Pizzorno J, Murray M
in the treatment of dysphoric moods. Cognit Ther Res 2:241-251, (eds): Textbook of Natural Medicine, 2nd ed. New York, Churchill
1987. Livingstone, 1999, pp 1039-1057.
8. Atlantis E, Chow CM, Kirby A, et al: An effective exercise-based 35. Shaw K, Turner J, Del Mar C: Tryptophan and 5-hydroxytryptophan
intervention for improving mental health and quality of life for depression. Cochrane Database Syst Rev (1):CD003198, 2002.
measures: A randomized controlled trial. Prev Med 39:424-434, 2004. 36. Klarskov K, Johnson KL, Benson LM, et al: Eosinophilia myalgia
9. Martinsen EW, Hoffart A, Solberg O: Comparing aerobic with syndrome case–associated contaminants in commercially available
nonaerobic forms of exercise in the treatment of clinical depression: 5-hydroxytryptophan. Adv Exp Med Biol 467:461-468, 1999.
A randomized trial. Compr Psychiatry 30:324-331, 1989. 37. Delle Chiaie R, Boissard G: Paper presented at the Sixth World
10. North TC, McCullagh P, Tran ZV: Effect of exercise on depression. Biological Psychiatry Congress [Abstract 90-56], June 22-27, 1997,
Exerc Sport Sci Rev 18:379-415, 1990. Nice, France.
11. Moore K: Exercise training as an alternative treatment for 38. Lake J: Psychotropic medications from natural products: A review of
depression among older adults. Altern Ther Health Med 4:48-56, promising research and recommendations. Altern Ther 6:36-60, 2000.
1998. 39. Bennet DA Jr, Phun L, Polk JF, et al: Neuropharmacology of St.
12. Fox KR: The influence of physical activity on mental well-being. John’s wort (Hypericum). Ann Pharmacother 32:1201-1208, 1998.
Public Health Nutr 2:411-418, 1999. 40. Hypericum Depression Trial Study Group: Effect of Hypericum
13. Babyak M, Blumenthal JA, Herman S, et al: Exercise treatment for perforatum (St. John’s wort) in major depressive disorder. JAMA
major depression: Maintenance of therapeutic benefit at 10 months. 287:1807-1814, 2002.
Psychosom Med 62:633-638, 2000. 41. Linde K, Mulrow CD, Berner M, et al: St John’s wort for depression.
14. Westover AN, Marangell LB: A cross-national relationship Cochrane Database Syst Rev (2):CD000448, 2005.
between sugar consumption and major depression? Depress 42. Szegedi A, Kohnen R, Dienel A, et al: Acute treatment of moderate
Anxiety 16:118-120, 2002. to severe depression with Hypericum extract WS 5570 (St John’s
15. Christensen L, Somers S: Comparison of nutrient intake among wort): Randomised controlled double-blind non-inferiority trial
depressed and nondepressed individuals. Int J Eat Disord 20: versus paroxetine. BMJ 330:503, 2005.
105-109, 1996. 43. Linde K, Ramirez G, Mulrow CD, et al: St. John’s wort for
16. Krietsch K, Christensen L, White B: Prevalence, presenting depression: An overview and meta-analysis of randomized clinical
symptoms, and psychological characteristics of individuals trials. BMJ 313:253-258, 1996.
experiencing a diet-related mood disturbance. Behav Ther 44. Schubert H, Halama P: Depressive episode primarily unresponsive to
19:593-604, 1988. therapy in elderly patients: Efficacy of Ginkgo biloba extract (Egb 761)
17. Gilliland K, Bullick W: Caffeine: A potential drug of abuse. Av Alcohol in combination with antidepressants. Geriatr Forsch 3:45-53, 1993.
Subst Abuse 3:53-73, 1984. 45. Lou H, Lieu P, Meng F, et al: Combined utilization of amitriptyline
18. Greden J: Caffeine and tobacco dependence. In Kaplan HI, Sadock and Ginkgo biloba extract in the treatment of depression: A multicenter
BJ (eds): Comprehensive Textbook of Psychiatry, 4th ed. Baltimore, randomized double-blind comparison [abstract only in English].
Williams & Wilkins, 1985, pp 1026-1033. Chinese Mental Health J 13:167-169, 1999.
19. Sullivan LE, Fiellin DA, O’Connor PG: The prevalence and impact 46. Frank E, Thase ME: Natural history and preventative treatment of
of alcohol problems in major depression: A systematic review. Am J recurrent mood disorders. Annu Rev Med 50:453-458, 1999.
Med 118:330-341, 2005. 47. Rakel RE: Depression. Prim Care 26:211-224, 1999.
20. Goodwin FK: Alcoholism research: Delivering on the promise. 48. Chilvers C, Dewey M, Fielding K, et al: Antidepressant drugs and
Public Health Rep 103:569-574, 1988. generic counseling for the treatment of major depression in
21. Bruinsma KA, Taren DL: Dieting, essential fatty acid intake, and primary care: Randomized trial with patient preference arms. BMJ
depression. Nutrition Rev 58:98-108, 2000. 322:772-775, 2001.
22. Tiemeier H, van Tuijl HR, Hofman A, et al: Plasma fatty acid 49. Reynolds WM, Coats KI: A comparison of cognitive behavioral
composition and depression are associated in the elderly: The therapy and relaxation training for the treatment of depression in
Rotterdam study, Am J Clin Nutr 78:40-46, 2003. adolescents, J Consult Clin Psychol 54:653-660, 1986.
23. Maes M, Smith R, Christophe A, et al: Fatty acid composition in 50. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, et al:
major depression: Decreased omega-3 fractions in cholesteryl esters Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in
and increased C20:4 omega-6/C20:5 omega-3 ratio in cholesteryl melancholia: A randomized comparison with electroconvulsive
esters and phospholipids. J Affect Disord 38:35-46, 1996. therapy (ECT) and imipramine. J Affect Disord 57:255-259, 2000.
24. Su KP, Huang SY, Chiu CC, et al: Omega-3 fatty acids in major 51. Han J: Electroacupuncture: An alternative to antidepressants for
depressive disorder: A preliminary double-blind, placebo-controlled treating affective diseases? Int J Neurosci 29:79-92, 1986.
trial. Eur Neuropsychopharmacol 13:267-271, 2003. 52. Ernst E, Rand JI, Stevinson C: Complementary therapies for
25. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to depression: An overview. Arch Gen Psychiatry 55:1026-1032, 1998.
maintenance medication treatment for recurrent unipolar depressive 53. Roschke J, Wolf CH, Muller MJ, et al: The benefit from whole-body
disorder. Am J Psychiatry 159:477-479, 2002. acupuncture in major depression. J Affect Disord 57:73-81, 2000.
26. Peet M, Horrobin DF: E-E Multicentre Study Group: A dose- 54. Macpherson H, Thomas K, Walters S, et al: The York acupuncture
ranging study of the effects of ethyl-eicosapentatenoate in patients safety study: Prospective survey of 34,000 treatments by traditional
with ongoing depression despite apparently adequate treatment with acupuncturists. BMJ 323:486-487, 2001.
standard drugs. Arch Gen Psychiatry 59:913-919, 2002. 55. Barrett B, Byford S, Knapp M: Evidence of cost-effective treatments
27. ConsumerLab.com: www.consumerlab.com/ for depression: A systematic review. J Affect Disord 84:1-13, 2005.